Hpx has been proven to be a candidate marker for progression of fibrosis in HCV patients (Cheung et al., 2009) and a potential biomarker of respiratory syncytial virus-infected pneumonia (Wang et al., 2016). The gene discussed is HPX; the disease is susceptibility to pneumonia measurement.